BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35343093)

  • 21. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
    Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
    J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expressions of cellular ATP-binding cassette transporters may be a promising diagnostic marker for colorectal cancer.
    Qutub RM; Al-Ghafari AB; Al Doghaither HA; Omar UM; Ghulam JM
    Saudi Med J; 2020 Aug; 41(8):834-840. PubMed ID: 32789424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications.
    Loktionov A; Soubieres A; Bandaletova T; Francis N; Allison J; Sturt J; Mathur J; Poullis A
    Br J Cancer; 2020 Jul; 123(2):252-260. PubMed ID: 32398859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
    Jiang JX; Zhang N; Liu ZM; Wang YY
    Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
    Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
    Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.
    Stonestreet J; Chandrapalan S; Woolley D; Uthman U; Arasaradnam RP
    Acta Gastroenterol Belg; 2019; 82(2):291-299. PubMed ID: 31314191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.
    Turvill J; Aghahoseini A; Sivarajasingham N; Abbas K; Choudhry M; Polyzois K; Lasithiotakis K; Volanaki D; Kim B; Langlands F; Andrew H; Roos J; Mellen S; Turnock D; Jones A
    Br J Gen Pract; 2016 Jul; 66(648):e499-506. PubMed ID: 27266863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum FBLN1 and STK31 as biomarkers of colorectal cancer and their ability to noninvasively differentiate colorectal cancer from benign polyps.
    Watany MM; Elmashad NM; Badawi R; Hawash N
    Clin Chim Acta; 2018 Aug; 483():151-155. PubMed ID: 29715435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal immunochemical test accuracy in average-risk colorectal cancer screening.
    Hernandez V; Cubiella J; Gonzalez-Mao MC; Iglesias F; Rivera C; Iglesias MB; Cid L; Castro I; de Castro L; Vega P; Hermo JA; Macenlle R; Martínez-Turnes A; Martínez-Ares D; Estevez P; Cid E; Vidal MC; López-Martínez A; Hijona E; Herreros-Villanueva M; Bujanda L; Rodriguez-Prada JI;
    World J Gastroenterol; 2014 Jan; 20(4):1038-47. PubMed ID: 24574776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
    Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
    Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.
    Jiang X; Bai XY; Li B; Li Y; Xia K; Wang M; Li S; Wu H
    Dis Markers; 2019; 2019():5069614. PubMed ID: 31481982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis.
    Song SE; Choi P; Kim JH; Jung K; Kim SE; Moon W; Park MI; Park SJ
    Korean J Gastroenterol; 2018 Jun; 71(6):332-337. PubMed ID: 29943560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
    Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
    Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
    Sun YH; Li J; Shu HJ; Li ZL; Qian JM
    Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.